Tech Company Financing Transactions

Portola Pharmaceuticals Funding Round

Portola Pharmaceuticals, based in South San Francisco, received $21 million in investment from MPM Capital, Prospect Venture Partners and Sutter Hill Ventures.

Transaction Overview

Company Name
Portola Pharmaceuticals
Announced On
12/8/2003
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Series A
Investors

MPM Capital (Lead Investor) (Nicholas Galakatos)

Prospect Venture Partners (Lead Investor) (Russell Hirsch)

Sutter Hill Ventures (Lead Investor) (Jeffrey Bird)

Abingworth (Michael Bigham)

Frazier Healthcare Partners (Alan Frazier)

Proceeds Purpose
Proceeds will be used to fund clinical programs and continue in-licensing efforts

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
270 E. Grand Ave.
South San Francisco, CA 94080
USA
Phone
(650) 246-7000
Website
www.portola.com
Email Address
[email protected]
Overview
Portola Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapeutics for acute and chronic cardiovascular and vascular disease. Portola has two drug candidates in clinical development.
Profile
Portola Pharmaceuticals LinkedIn Company Profile
Social Media
Portola Pharmaceuticals Company Twitter Account
Company News
Portola Pharmaceuticals News
Facebook
Portola Pharmaceuticals on Facebook
YouTube
Portola Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Financial Officer
Mard Dier
  Mard Dier LinkedIn Profile  Mard Dier Twitter Account  Mard Dier News  Mard Dier on Facebook
Chief Medical Officer
John Lawrence?
  John Lawrence? LinkedIn Profile  John Lawrence? Twitter Account  John Lawrence? News  John Lawrence? on Facebook
VP - Bus. Development
Tao Fu
  Tao Fu LinkedIn Profile  Tao Fu Twitter Account  Tao Fu News  Tao Fu on Facebook
VP - Engineering
Glenn Brame
  Glenn Brame LinkedIn Profile  Glenn Brame Twitter Account  Glenn Brame News  Glenn Brame on Facebook
VP - General Counsel
John Moriarty
  John Moriarty LinkedIn Profile  John Moriarty Twitter Account  John Moriarty News  John Moriarty on Facebook
VP - R & D
John Curnutte
  John Curnutte LinkedIn Profile  John Curnutte Twitter Account  John Curnutte News  John Curnutte on Facebook

 

 

Browse more venture capital transactions:

Prev: 12/8/2003: Azanda Network Devices venture capital transaction
Next: 12/9/2003: Red Bend Software venture capital transaction

 

Share this article

 

About Database of VC Transactions

We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.